Normal view MARC view ISBD view

Idelalisib and rituximab for chronic lymphocytic leukaemia.

Stirrups, Robert

Idelalisib and rituximab for chronic lymphocytic leukaemia. [electronic resource] - The Lancet. Oncology 06 2019 - e294 p. digital

Publication Type: Journal Article; Comment

ISSN: 1474-5488

Standard No.: 10.1016/S1470-2045(19)30250-5 doi

Subjects--Topical Terms:
Humans
Leukemia, Lymphocytic, Chronic, B-Cell
Purines
Quinazolinones
Rituximab

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)